Union Minister Mansukh Mandaviya urges to boost local production of medical devices, says sector has potential growth

Mandaviya urged industry participants to make concrete efforts toward increasing the localization impact and deepen the domestic manufacturing of components.

Published On 2022-03-11 05:37 GMT   |   Update On 2022-03-11 05:37 GMT
Advertisement

New Delhi: Union minister Mansukh Mandaviya has exhorted the industry to take concrete efforts towards increasing local production of medical devices while stressing that the sector has huge potential for growth in the domestic as well in global markets, the Chemicals and Fertilizers Ministry said on Wednesday. In a meeting held on Tuesday, Mandaviya interacted with six industry participants of the PLI schemes for medical devices that have successfully commissioned projects, the ministry said in a release.

Advertisement

The minister noted that the medical devices sector in the country has huge potential for growth in domestic as well in global markets.

He stated that manufacturing of medical devices in India shall be a significant step forward in strengthening the domestic supply chain, it added.

Mandaviya urged industry participants to make concrete efforts toward increasing the localization impact and deepen the domestic manufacturing of components, the release said.

The minister also encouraged the industry players to work towards reducing the import-export trade gap in the sector.
Representatives from Panacea Medical Technologies, Trivitron Healthcare, Philips Global Business Services, Microtek New Technologies, Sahajanand Medical Technologies, and Deck Mount Electronics Limited participated in the meeting.
The Department of Pharmaceuticals had launched the PLI scheme for promoting domestic manufacturing of medical devices in March 2020.
Under the scheme, the financial incentive is given to selected companies at the rate of 5 percent of incremental sales of medical devices manufactured in India and covered under the target segments of the scheme, for a period of five (5) years till 2027-28.
The total financial outlay of the scheme is Rs 3,420 crore.
Till date, a total of 21 applicants have been approved for 49 products, with a potential to utilize incentive amount of Rs 2,541 crore, the release stated.




Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News